The Latest Breaking News from Nasdaq

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Belden (NYSE: BDC) over Encore Wire Corp (NASDAQ: WIRE).

Wejo Group Limited (NASDAQ: WEJO) has collaborated with Ford Motor Company (NYSE: F) in Europe, which gives Wejo access to personalized connected vehicle data from Ford vehicles across the continent. 

U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall…

  Cognyte Software (NASDAQ:CGNT) reported its Q1 earnings results on Tuesday, June 28, 2022 at 07:10 AM. Here's what investors need to know about the announcement. Earnings Cognyte Software reported an EPS of $-0.79.

By John Vandermosten, CFA NASDAQ:BCTX READ THE FULL BCTX RESEARCH REPORT

Cathie Wood-led Ark Investment Management on Monday scooped up more shares of TuSimple Holdings Inc (NASDAQ: TSP), its fourth buy in the self-driving truck startup this month.

Starbucks Corporation (NASDAQ: SBUX) and Samsung are collaborating on cases for Galaxy devices that feature the coffee chain's branding.

Britain-based proxy advisers Pensions & Investment Research Consultants (PIRC) sought more transparent tax and financial information from Microsoft Corp (NASDAQ:MSFT) and Cisco Systems, Inc (NASDAQ:CSCO), Reuters reports. The resolution urged Microsoft to disclose financial and tax information country-by-country outside the U.S. to help investors assess its fairness and identify any risks posed by tax reforms. It also…

Global cybersecurity, AI, and IoT company WISeKey International Holding AG (NASDAQ:WKEY) transferred its 51% stake in German Artificial Intelligence Platform company arago GmbH to OGARA GmbH. The transfer of the shares gives OGARA complete control of arago's operations into the acquiring consortium and establishes the partnership between WISeKey and arago to work on the…

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

ESSA Pharma Inc (NASDAQ:EPIX) presented clinical results from the Phase 1a dose-escalation study of EPI-7386 as a monotherapy for metastatic castration-resistant prostate cancer (mCRPC) resistant to current standard-of-care therapies.  The initial data from 36 patients demonstrate that EPI-7386 was well-tolerated, exhibited a favorable pharmacokinetic profile, and demonstrated initial anti-tumor activity in a heavily…